IDSA Home

What's New

More than $1.7 Million in IDSA Foundation Grant Funds Attracts Diverse Minds to Alzheimer’s Research

The grant funds, which were awarded through the Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program, were dispersed among 11 researchers representing a wide range of research fields and institutions across the U.S.

IDSA Response to CDC’s Updates on Masking Guidance

The Omicron SARS-CoV-2 variant is more transmissible than earlier variants, which means that wearing the right mask is even more important.

Become a Fellow of IDSA: New Application Timeline, Same Professional Excellence

Applications are now open to apply for FIDSA. Fellowship in IDSA honors members who have achieved professional excellence and provided significant service to the profession in clinical practice, research, administration or education. Apply for fellowship by Feb. 23.

Recommendations for Ensuring Equitable Access to Oral Therapies for Treating COVID-19

Many hospitals and health departments are experiencing the greatest strain on their systems and workforce since the COVID-19 pandemic was declared nearly two years ago.

Infectious Diseases Society of America Announces Next Editor-in-Chief of The Journal of Infectious Diseases

IDSA is pleased to announce that Cynthia L. Sears, MD, FIDSA, has been selected as the next editor-in-chief of The Journal of Infectious Diseases. Dr. Sears will succeed Martin S. Hirsch, MD, FIDSA, at the end of 2022, following his distinguished two decades of service to JID.

What You Need to Know About COVID-19 and the Omicron Variant

As scientists and clinicians learn more about the Omicron variant, IDSA highlights four things we know right now that can help reduce transmission and the risk of disease.